Recent progress in microarray technology has been related to the development of high resolution microarrays which can map genomic alterations and constitutional variants in DNA copy number at an extremely high resolution. We have applied high resolution arrays in this fashion to several systems and have also adapted this technology to the mapping of DNase I hypersensitive sites. Recently, we have demonstrated that they can be used to map DNA origins of replication. We have also worked to push the limits of detection by extending sample types to formalin fixed, paraffin embedded samples, flow sorted primary cells and fine needle aspirates. We have established that useful nucleic acid preparations can be obtained from these fixed tissues and are continuing to extend the analysis of this material for a wider range of genomic technologies. Current efforts have been directed primarily at the implementation of next generation sequencing technologies. These methods primarily depend on producing an array of DNA molecules which are sequentially imaged during the sequencing reaction. We are investigating the use of these methods for gene expression profiling for large and small RNAs, for the detection of genome rearrangements, mutations, and for the measurement of chromatin modifications, DNase I hypersensitive sites, and transcription factor localization. A major part of this effort is the development of a powerful computational environment which can be used to analyze the massive amount of sequence data which is generated by this work. Although this is a challenging process, it ultimately will yield a streamlined analysis pipeline in which multiple sequence based assays will be easy to integrate and free of array platform specific artifacts. Specific goals of our computational efforts include the optimization of pipelines to process sequence data for chromatin analysis, chromosome rearrangements, gene expression, and mutation detection. We are currently engaged in pursuing new approaches to target sequencing efforts to the small proportion of the genome composed of genes in order to be able to sequence thousands of genes in individual samples and in a complementary fashion, to sequence a few key genes in hundreds of samples. These are goals are being accomplished with the aid of thousands of synthetic oligonucleotides which are used to target the desired portion of the genome.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIABC011091-04
Application #
8349322
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
2011
Total Cost
$1,475,430
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code
Oltmann, Johanna; Heselmeyer-Haddad, Kerstin; Hernandez, Leanora S et al. (2018) Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients. Genes Chromosomes Cancer 57:165-175
Shukla, Vivek; Rao, Mahadev; Zhang, Hongen et al. (2018) Identification of Novel Targets for Lung Cancer Therapy Using an Induced Pluripotent Stem Cell Model. Ann Am Thorac Soc 15:S127-S128
Sourbier, Carole; Liao, Pei-Jyun; Ricketts, Christopher J et al. (2018) Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers. Oncotarget 9:10723-10733
Hirsch, Daniela; Wangsa, Darawalee; Zhu, Yuelin J et al. (2018) Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis. Clin Cancer Res :
Ciftci-Yilmaz, Sultan; Au, Wei-Chun; Mishra, Prashant K et al. (2018) A Genome-Wide Screen Reveals a Role for the HIR Histone Chaperone Complex in Preventing Mislocalization of Budding Yeast CENP-A. Genetics 210:203-218
Lee, Joo Sang; Das, Avinash; Jerby-Arnon, Livnat et al. (2018) Harnessing synthetic lethality to predict the response to cancer treatment. Nat Commun 9:2546
Kouprina, Natalay; Liskovykh, Mikhail; Lee, Nicholas C O et al. (2018) Analysis of the 9p21.3 sequence associated with coronary artery disease reveals a tendency for duplication in a CAD patient. Oncotarget 9:15275-15291
Quan, Xin Xin; Hawk, Nga Voong; Chen, Weiping et al. (2018) Targeting Notch1 and IKK? Enhanced NF-?B Activation in CD133+ Skin Cancer Stem Cells. Mol Cancer Ther 17:2034-2048
Moreno-Smith, Myrthala; Halder, J B; Meltzer, Paul S et al. (2018) ATP11B mediates platinum resistance in ovarian cancer. J Clin Invest 128:3199
Rozenblum, Ester; Sotelo-Silveira, Jose R; Kim, Gina Y et al. (2017) Novel near-diploid ovarian cancer cell line derived from a highly aneuploid metastatic ovarian tumor. PLoS One 12:e0182610

Showing the most recent 10 out of 115 publications